C-reactive protein (CRP) and serum amyloid A protein (SAA) are non-redundantly regulated by IL-6 [159] and therefore are not suitable to monitor the inflammatory status or concomitant infections in patients receiving IL-6 blocking drugs. The gene discussed is CRP; the disease is infection.